 Johnson & Johnson has agreed to buy medical technology firm Guidant for $25.4bn (Â£13bn) Guidant is a key producer of equipment that combats heart problems such as implant defibrillators and pacemakers . Deal aimed at offsetting J&J's reliance on slowing drug business .